William Blair & Company’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.72M | Sell |
7,852
-230
| -3% | -$116K | 0.01% | 571 |
|
|
2025
Q4 | $3.77M | Sell |
8,082
-808
| -9% | -$375K | 0.01% | 592 |
|
|
2025
Q3 | $3.79M | Sell |
8,890
-110
| -1% | -$42.6K | 0.01% | 589 |
|
|
2025
Q2 | $3.45M | Buy |
9,000
+425
| +5% | +$153K | 0.01% | 591 |
|
|
2025
Q1 | $2.96M | Sell |
8,575
-175
| -2% | -$56.3K | 0.01% | 618 |
|
|
2024
Q4 | $2.63M | Sell |
8,750
-820
| -9% | -$287K | 0.01% | 655 |
|
|
2024
Q3 | $3.89M | Buy |
9,570
+106
| +1% | +$38.8K | 0.01% | 558 |
|
|
2024
Q2 | $3.04M | Buy |
9,464
+998
| +12% | +$324K | 0.01% | 591 |
|
|
2024
Q1 | $2.82M | Sell |
8,466
-135
| -2% | -$41.3K | 0.01% | 602 |
|
|
2023
Q4 | $2.33M | Buy |
8,601
+406
| +5% | +$100K | 0.01% | 642 |
|
|
2023
Q3 | $2.02M | Sell |
8,195
-54
| -0.7% | -$14.8K | 0.01% | 652 |
|
|
2023
Q2 | $2.5M | Sell |
8,249
-69
| -0.8% | -$19.2K | 0.01% | 616 |
|
|
2023
Q1 | $2.19M | Sell |
8,318
-275
| -3% | -$69.9K | 0.01% | 637 |
|
|
2022
Q4 | $2.06M | Sell |
8,593
-80
| -0.9% | -$17.9K | 0.01% | 624 |
|
|
2022
Q3 | $1.59M | Buy |
8,673
+118
| +1% | +$23.5K | 0.01% | 673 |
|
|
2022
Q2 | $1.44M | Sell |
8,555
-266
| -3% | -$57.1K | 0.01% | 724 |
|
|
2022
Q1 | $2.21M | Buy |
8,821
+44
| +0.5% | +$11K | 0.01% | 677 |
|
|
2021
Q4 | $2.25M | Buy |
8,777
+272
| +3% | +$66.6K | 0.01% | 699 |
|
|
2021
Q3 | $2.06M | Sell |
8,505
-38
| -0.4% | -$9.29K | 0.01% | 698 |
|
|
2021
Q2 | $1.77M | Buy |
8,543
+91
| +1% | +$18.5K | 0.01% | 738 |
|
|
2021
Q1 | $1.59M | Sell |
8,452
-395
| -4% | -$69.7K | 0.01% | 755 |
|
|
2020
Q4 | $1.46M | Sell |
8,847
-136
| -2% | -$19.9K | 0.01% | 737 |
|
|
2020
Q3 | $1.12M | Buy |
8,983
+782
| +10% | +$96.8K | ﹤0.01% | 725 |
|
|
2020
Q2 | $796K | Buy |
8,201
+954
| +13% | +$99.2K | ﹤0.01% | 790 |
|
|
2020
Q1 | $651K | Sell |
7,247
-1,529
| -17% | -$198K | ﹤0.01% | 797 |
|
|
2019
Q4 | $1.3M | Buy |
8,776
+998
| +13% | +$134K | 0.01% | 715 |
|
|
2019
Q3 | $937K | Sell |
7,778
-929
| -11% | -$120K | 0.01% | 767 |
|
|
2019
Q2 | $1.18M | Buy |
8,707
+5,862
| +206% | +$741K | 0.01% | 718 |
|
|
2019
Q1 | $371K | Buy |
2,845
+1,088
| +62% | +$146K | ﹤0.01% | 1065 |
|
|
2018
Q4 | $219K | Buy |
+1,757
| New | +$236K | ﹤0.01% | 1203 |
|
|
2015
Q4 | – | Sell |
-2,794
| Closed | -$216K | – | 1243 |
|
|
2015
Q3 | $216K | Sell |
2,794
-881
| -24% | -$78K | ﹤0.01% | 1257 |
|
|
2015
Q2 | $333K | Sell |
3,675
-55,516
| -94% | -$4.45M | ﹤0.01% | 1895 |
|
|
2015
Q1 | $4.45M | Buy |
59,191
+1,043
| +2% | +$74.9K | 0.01% | 1077 |
|
|
2014
Q4 | $4.27M | Sell |
58,148
-8,494
| -13% | -$597K | 0.01% | 1077 |
|
|
2014
Q3 | $4.7M | Sell |
66,642
-38,638
| -37% | -$2.55M | 0.01% | 1038 |
|
|
2014
Q2 | $5.93M | Buy |
105,280
+5,364
| +5% | +$283K | 0.01% | 973 |
|
|
2014
Q1 | $5.25M | Buy |
+99,916
| New | +$4.97M | 0.01% | 968 |
|
Other funds holding HCA
VCM
VPM
William Blair & Company's HCA Position: Q1 2026 in Review
William Blair & Company reduced its HCA Healthcare (HCA) stake by 2.8% in Q1 2026, selling an estimated $116K and leaving 7,852 shares worth $3.72M. The position accounts for 0.01% of the portfolio, ranked #571.
William Blair & Company first reported a position in HCA in Q1 2014 and has held it in 37 quarters since. The position peaked at $5.93M in Q2 2014. 1,415 funds tracked by Wall St. Rank hold HCA as of Q1 2026.
- William Blair & Company held 7,852 shares of HCA Healthcare worth $3.72M as of Q1 2026.
- William Blair & Company sold 230 HCA Healthcare shares in Q1 2026, an estimated $116K.
- HCA Healthcare made up 0.01% of William Blair & Company's portfolio in Q1 2026, its #571 holding.
- William Blair & Company first reported a position in HCA Healthcare in Q1 2014 and has held it in 37 quarters since.
- William Blair & Company's HCA Healthcare position peaked at $5.93M in Q2 2014.
- 1,415 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.
Based on William Blair & Company's 13F filing for Q1 2026, filed 8 May 2026.